The National Institutes of Health (NIH) /National Institutes of Allergy and Infectious Disease (NIAID) have a requirement for ExpiFectamine Rgnt Enhcrs 50L reagents and EXPI1293 Expression Medium from Life Technologies 3175 Staley Road, Grand Island, New York 14072. Life Technologies is the original manufacturer of these reagents. These specific reagents are required to ensure consistency for analysis of essential data for the continuity of on-going research on viruses and development of vaccines. Changing reagents at this time would compromise on-going experiments and prevent proper interpretation of the results. The Item/Description/Quantity: 1) EXPIFECTAMINE RGNT ENHCRS 50L 50L Kit, qty. 5 ea , 2) EXPI293 EXPRESSION MEDIUM 6 x 1L, qty. 25 ea. This is a brand name of equal solicitation in accordance with FAR 52. 211-6. The government will award a fixed price purchase order to the responsible contractor who can provide the same brand or similar reagents. Offerors providing other that the Life Technologies brand must provide technical specifications and Past Performance providing similar products that were successfully substitutes for the requested brand. All Offerors must be registered in the SAM database prior to award, during performance, and through final payment of any contract. The SAM website is http://www.sam.gov. All responsible sources may submit a proposal by Wednesday, September 3, 2014 that will be considered. Point of contact concerning this requirement is Lawrence Bland who can be reached by e-mail at
[email protected].